Must See: Do You Invest in Midcap Stocks? Here's a Great News for You
Here is the latest financial fact sheet of INDOCO REMEDIES. For more details, see the INDOCO REMEDIES quarterly results and INDOCO REMEDIES share price. For a sector overview, read our pharmaceuticals sector report.
1 Day | % | 1.1 |
No. of shares | m | 92.18 |
1 Week | % | -3.3 |
1 Month | % | 3.3 |
1 Year | % | 3.3 |
52 week H/L | Rs | 417.0/307.0 |
No. of Mths Year Ending |
12 Mar-19* |
12 Mar-20* |
12 Mar-21* |
12 Mar-22* |
12 Mar-23* |
5-Yr Chart Click to enlarge
|
---|
INDOCO REMEDIES EQUITY SHARE DATA | |||||||
---|---|---|---|---|---|---|---|
High | Rs | 238 | 272 | 336 | 530 | 423 | |
Low | Rs | 150 | 133 | 190 | 285 | 308 | |
Sales per share (Unadj.) | Rs | 105.1 | 120.1 | 134.7 | 167.2 | 181.1 | |
Earnings per share (Unadj.) | Rs | -0.3 | 2.6 | 10.1 | 16.8 | 15.4 | |
Diluted earnings per share | Rs | -0.3 | 2.6 | 10.1 | 16.8 | 15.4 | |
Cash flow per share (Unadj.) | Rs | 7.5 | 10.3 | 18.0 | 25.4 | 23.1 | |
Dividends per share (Unadj.) | Rs | 0.30 | 0.30 | 1.50 | 2.25 | 2.25 | |
Adj. dividends per share | Rs | 0.30 | 0.30 | 1.50 | 2.25 | 2.25 | |
Avg Dividend yield | % | 0.2 | 0.1 | 0.6 | 0.6 | 0.6 | |
Book value per share (Unadj.) | Rs | 71.7 | 73.7 | 83.4 | 98.2 | 111.5 | |
Adj. book value per share | Rs | 71.7 | 73.7 | 83.4 | 98.1 | 111.5 | |
Shares outstanding (eoy) | m | 92.15 | 92.15 | 92.15 | 92.15 | 92.15 | |
Price / Sales ratio | x | 1.8 | 1.7 | 2.0 | 2.4 | 2.0 | |
Avg P/E ratio | x | -616.0 | 77.5 | 26.0 | 24.3 | 23.7 | |
P/CF ratio (eoy) | x | 26.1 | 19.7 | 14.6 | 16.1 | 15.8 | |
Price / Book Value ratio | x | 2.7 | 2.7 | 3.1 | 4.1 | 3.3 | |
Dividend payout | % | -95.2 | 11.5 | 14.9 | 13.4 | 14.6 | |
Avg Mkt Cap | Rs m | 17,889 | 18,683 | 24,215 | 37,540 | 33,683 | |
Total wages/salary | Rs m | 2,317 | 2,565 | 2,740 | 2,963 | 3,226 |
INDOCO REMEDIES INCOME DATA | |||||||
---|---|---|---|---|---|---|---|
Net Sales | Rs m | 9,684 | 11,066 | 12,415 | 15,408 | 16,686 | |
Other income | Rs m | 67 | 48 | 91 | 34 | 24 | |
Total revenues | Rs m | 9,751 | 11,114 | 12,506 | 15,442 | 16,710 | |
Gross profit | Rs m | 766 | 1,208 | 2,183 | 3,263 | 2,860 | |
Depreciation | Rs m | 716 | 708 | 731 | 790 | 706 | |
Interest | Rs m | 211 | 263 | 223 | 141 | 250 | |
Profit before tax | Rs m | -93 | 286 | 1,320 | 2,366 | 1,928 | |
Minority Interest | Rs m | 0 | 0 | 0 | 0 | 0 | |
Prior Period Items | Rs m | 0 | 0 | 0 | 0 | 0 | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | 0 | 0 | 0 | |
Tax | Rs m | -64 | 45 | 390 | 818 | 505 | |
Profit after tax | Rs m | -29 | 241 | 930 | 1,548 | 1,423 | |
Gross profit margin | % | 7.9 | 10.9 | 17.6 | 21.2 | 17.1 | |
Effective tax rate | % | 68.8 | 15.6 | 29.5 | 34.6 | 26.2 | |
Net profit margin | % | -0.3 | 2.2 | 7.5 | 10.0 | 8.5 |
INDOCO REMEDIES BALANCE SHEET DATA | |||||||
---|---|---|---|---|---|---|---|
Current assets | Rs m | 5,381 | 5,631 | 6,225 | 8,669 | 8,082 | |
Current liabilities | Rs m | 4,455 | 4,590 | 4,069 | 5,182 | 4,245 | |
Net working cap to sales | % | 9.6 | 9.4 | 17.4 | 22.6 | 23.0 | |
Current ratio | x | 1.2 | 1.2 | 1.5 | 1.7 | 1.9 | |
Inventory Days | Days | 12 | 12 | 22 | 8 | 25 | |
Debtors Days | Days | 738 | 693 | 687 | 704 | 768 | |
Net fixed assets | Rs m | 6,845 | 6,764 | 7,117 | 7,125 | 9,055 | |
Share capital | Rs m | 184 | 184 | 184 | 184 | 184 | |
"Free" reserves | Rs m | 6,422 | 6,611 | 7,506 | 8,862 | 10,092 | |
Net worth | Rs m | 6,606 | 6,796 | 7,690 | 9,046 | 10,276 | |
Long term debt | Rs m | 1,287 | 969 | 969 | 959 | 1,435 | |
Total assets | Rs m | 12,225 | 12,396 | 13,343 | 15,794 | 17,137 | |
Interest coverage | x | 0.6 | 2.1 | 6.9 | 17.7 | 8.7 | |
Debt to equity ratio | x | 0.2 | 0.1 | 0.1 | 0.1 | 0.1 | |
Sales to assets ratio | x | 0.8 | 0.9 | 0.9 | 1.0 | 1.0 | |
Return on assets | % | 1.5 | 4.1 | 8.6 | 10.7 | 9.8 | |
Return on equity | % | -0.4 | 3.5 | 12.1 | 17.1 | 13.8 | |
Return on capital | % | 1.5 | 7.1 | 17.8 | 25.1 | 18.6 | |
Exports to sales | % | 29.5 | 32.0 | 43.7 | 42.6 | 47.5 | |
Imports to sales | % | 11.2 | 10.7 | 10.2 | 10.5 | 11.5 | |
Exports (fob) | Rs m | 2,858 | 3,543 | 5,426 | 6,565 | 7,919 | |
Imports (cif) | Rs m | 1,085 | 1,187 | 1,270 | 1,613 | 1,917 | |
Fx inflow | Rs m | 2,858 | 3,543 | 5,426 | 6,565 | 7,919 | |
Fx outflow | Rs m | 1,085 | 1,187 | 1,270 | 1,613 | 1,917 | |
Net fx | Rs m | 1,773 | 2,357 | 4,157 | 4,952 | 6,002 |
INDOCO REMEDIES CASH FLOW | |||||||
---|---|---|---|---|---|---|---|
From Operations | Rs m | 1,321 | 1,228 | 822 | 1,738 | 1,788 | |
From Investments | Rs m | -1,038 | -559 | -667 | -1,214 | -2,082 | |
From Financial Activity | Rs m | -161 | -639 | -299 | -444 | 228 | |
Net Cashflow | Rs m | 122 | 30 | -143 | 80 | -65 |
Share Holding
Shareholding as on Dec 2023
|
Company Information
|
CHM: Suresh G Kare | COMP SEC: Jayshankar Menon | YEAR OF INC: 1947 | BSE CODE: 532612 | FV (Rs): 2 | DIV YIELD (%): 0.7 |
Read: INDOCO REMEDIES 2022-23 Annual Report Analysis
More Pharmaceuticals Company Fact Sheets: DIVIS LABORATORIES DR. REDDYS LAB ZYDUS LIFESCIENCES SUN PHARMA CIPLA
Compare INDOCO REMEDIES With: DIVIS LABORATORIES DR. REDDYS LAB ZYDUS LIFESCIENCES SUN PHARMA CIPLA
Indian share markets Slipped further as the session progressed and ended the day weak.